The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported hematoma was due to procedural circumstances.The reported patient effect of hematoma, as listed in the mitraclip system instructions for use is a known possible complication associated with mitraclip procedures.The reported minor injury/ illness/ impairment was the result of case-specific circumstances as no specific treatment was given to the reported hematoma.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report a hematoma.It was reported that on (b)(6) 2022, a mitraclip procedure was performed for a functional mitral regurgitation (mr) with a grade of 4.It was noted that the patient had restricted leaflet motion, a coaptation gap medial of a2/p2, and a thick lipomatous septum.The clip delivery system (cds) was advanced in the patient and two attempts to grasp the leaflets were made, but each time it ended up too medial with little reduction in mr.During the third grasping attempt, an intracardiac hematoma was noted on the superior aspect of left atrium and verified under transesophageal echocardiogram (tee) with a size of 6.08 cm.Procedure was aborted and the physician started monitoring the hematoma under tee.The physician believes the hematoma was caused from a dissection plane during difficulty gaining transseptal access with a non-abbott wire.However, the mitraclip system may have contributed to the propagation of the hematoma.No additional information was provided.
|